Join
Live feed
·
PRReleasevia Quantisnow
Phathom Pharmaceuticals Inc. logo

Phathom Pharmaceuticals Announces Positive Topline Results from PHALCON-EE Pivotal Phase 3 Erosive Esophagitis Trial

ByQuantisnow·Wall Street's wire, on your screen.
PHAT· Phathom Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHAT (Phathom Pharmaceuticals Inc.) and more on Quantisnow.